167 related articles for article (PubMed ID: 15190299)
1. Dose intensity or monoclonal antibody in first-line treatment.
Coiffier B
Hematol J; 2004; 5 Suppl 3():S154-8. PubMed ID: 15190299
[No Abstract] [Full Text] [Related]
2. Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation.
Tsai D; Moore H; Hardy C; Porter D; Loh E; Vaughn D; Luger S; Schuster S; Stadtmauer E
Bone Marrow Transplant; 1999 Sep; 24(5):521-6. PubMed ID: 10482937
[TBL] [Abstract][Full Text] [Related]
3. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
Collins-Burow B; Santos ES
Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
5. 6. Report on workshop: EBMT workshop "High dose therapy in aggressive NHL".
Schmitz N
Ann Hematol; 2001; 80 Suppl 3():B24-5. PubMed ID: 11757700
[No Abstract] [Full Text] [Related]
6. Indications for early autologous stem cell transplantation in aggressive lymphoma.
Kluin-Nelemans HC
Ann Hematol; 2001; 80 Suppl 3():B121-2. PubMed ID: 11757692
[No Abstract] [Full Text] [Related]
7. Peripheral T-cell lymphoma following rituximab therapy for B-cell lymphoma.
Micallef IN; Kirk A; Norton A; Foran JM; Rohatiner AZ; Lister TA
Blood; 1999 Apr; 93(7):2427-8. PubMed ID: 10215354
[No Abstract] [Full Text] [Related]
8. Primary large B-cell lymphoma of the bone marrow.
Hishizawa M; Okamoto K; Chonabayashi K; Kaneko H; Watanabe M; Tsudo M
Br J Haematol; 2007 Feb; 136(3):351. PubMed ID: 17233843
[No Abstract] [Full Text] [Related]
9. The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma.
Villanueva ML; Vose JM
Clin Adv Hematol Oncol; 2006 Jul; 4(7):521-30. PubMed ID: 17147239
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphoma.
Vose JM
Ann Oncol; 1998; 9 Suppl 1():S1-3. PubMed ID: 9581234
[TBL] [Abstract][Full Text] [Related]
11. High-dose therapy with stem cell infusion in lymphoma.
Cohen SC; Krigel RL
Semin Oncol; 1995 Jun; 22(3):218-29. PubMed ID: 7777866
[No Abstract] [Full Text] [Related]
12. Who should receive myeloablative therapy for diffuse large B-cell lymphoma?
Wannesson L; Zucca E
Nat Clin Pract Oncol; 2008 Aug; 5(8):442-3. PubMed ID: 18607392
[No Abstract] [Full Text] [Related]
13. Rituximab in high-grade lymphoma.
Zwick C; Murawski N; Pfreundschuh M;
Semin Hematol; 2010 Apr; 47(2):148-55. PubMed ID: 20350662
[TBL] [Abstract][Full Text] [Related]
14. [Role of high-dose chemotherapy and autologous blood stem cell transplantation in patients with diffuse large B-cell lymphoma].
Gavrilina OA; Gabeeva NG; Morozova AK; Sidorova AA; Zvonkov EE
Ter Arkh; 2013; 85(7):90-7. PubMed ID: 24137955
[TBL] [Abstract][Full Text] [Related]
15. [Progress in therapeutic strategy for malignant lymphoma].
Ogura M
Gan To Kagaku Ryoho; 2005 Mar; 32(3):309-27. PubMed ID: 15791814
[TBL] [Abstract][Full Text] [Related]
16. [Recent therapeutic progress in non-Hodgkin lymphoma: focusing on diffuse large B-cell lymphoma and follicular lymphoma].
Ogura M
Rinsho Ketsueki; 2008 Oct; 49(10):1434-50. PubMed ID: 18833928
[No Abstract] [Full Text] [Related]
17. [Malignant lymphoma (Hodgkin lymphoma and non-Hodgkin lymphoma)].
Kinoshita T
Rinsho Ketsueki; 2012 Feb; 53(2):145-54. PubMed ID: 22450573
[No Abstract] [Full Text] [Related]
18. High-dose therapy for diffuse large-cell lymphoma in first remission.
Perry AR; Goldstone AH
Ann Oncol; 1998; 9 Suppl 1():S9-14. PubMed ID: 9581236
[TBL] [Abstract][Full Text] [Related]
19. Rituximab Improves Rate and Duration of Chemotherapy-Induced Remissions in Indolent and Aggressive Non-Hodgkin's Lymphoma.
Gibson AD
Clin Lymphoma; 2004 Sep; 5(2):81-3. PubMed ID: 15453921
[No Abstract] [Full Text] [Related]
20. Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897).
Todeschini G; Tecchio C; Pasini F; Benedetti F; Cantini M; Crippa C; Draisci M; Pizzolo G
Cancer; 2005 Aug; 104(3):555-60. PubMed ID: 15959910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
